Theranostics - a sure cure for cancer after 100 years?
Cancer has remained a formidable challenge in medicine and has claimed an enormous number of lives worldwide. Theranostics, combining diagnostic methods with personalized therapeutic approaches, shows huge potential to advance the battle against cancer. This review aims to provide an overview of the...
Gespeichert in:
Veröffentlicht in: | Theranostics 2024-01, Vol.14 (6), p.2464-2488 |
---|---|
Hauptverfasser: | , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 2488 |
---|---|
container_issue | 6 |
container_start_page | 2464 |
container_title | Theranostics |
container_volume | 14 |
creator | Song, Yangmeihui Zou, Jianhua Castellanos, E Alejandro Matsuura, Naomi Ronald, John A Shuhendler, Adam Weber, Wolfgang A Gilad, Assaf A Müller, Cristina Witney, Timothy H Chen, Xiaoyuan |
description | Cancer has remained a formidable challenge in medicine and has claimed an enormous number of lives worldwide. Theranostics, combining diagnostic methods with personalized therapeutic approaches, shows huge potential to advance the battle against cancer. This review aims to provide an overview of theranostics in oncology: exploring its history, current advances, challenges, and prospects. We present the fundamental evolution of theranostics from radiotherapeutics, cellular therapeutics, and nanotherapeutics, showcasing critical milestones in the last decade. From the early concept of targeted drug delivery to the emergence of personalized medicine, theranostics has benefited from advances in imaging technologies, molecular biology, and nanomedicine. Furthermore, we emphasize pertinent illustrations showcasing that revolutionary strategies in cancer management enhance diagnostic accuracy and provide targeted therapies customized for individual patients, thereby facilitating the implementation of personalized medicine. Finally, we describe future perspectives on current challenges, emerging topics, and advances in the field. |
doi_str_mv | 10.7150/thno.96675 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11024861</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3043778598</sourcerecordid><originalsourceid>FETCH-LOGICAL-c338t-d3a19aa6abdff813a7b400153ca5a927dae860c5d3e5d0743b456e384e846ac83</originalsourceid><addsrcrecordid>eNpVkE1Lw0AQhhdRbKm9-AMkRxFSd7ufORUpfkHBSz0vk83ERtJs3U2F_nsTW0udw8zAvLzv8BByzehEM0nv21XjJ5lSWp6RITPcpFoJen6yD8g4xk_alaDTjGWXZMCNEkoJMyRqucIAjY9t5WKSJpDEbcDE9a30IXHQOAwJlG3XGaXJDiHE2RW5KKGOOD7MEXl_elzOX9LF2_Pr_GGROs5NmxYcWAagIC_K0jAOOheUMskdSMimugA0ijpZcJQF1YLnQirkRqARCpzhIzLb-262-RoLh00boLabUK0h7KyHyv6_NNXKfvhvyxidCqNY53B7cAj-a4uxtesqOqxraNBvo-VUcK2NzPqwu73UBR9jwPKYw6jtYdsetv2F3YlvTj87Sv_Q8h9ts3nY</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3043778598</pqid></control><display><type>article</type><title>Theranostics - a sure cure for cancer after 100 years?</title><source>PubMed Central Open Access</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Song, Yangmeihui ; Zou, Jianhua ; Castellanos, E Alejandro ; Matsuura, Naomi ; Ronald, John A ; Shuhendler, Adam ; Weber, Wolfgang A ; Gilad, Assaf A ; Müller, Cristina ; Witney, Timothy H ; Chen, Xiaoyuan</creator><creatorcontrib>Song, Yangmeihui ; Zou, Jianhua ; Castellanos, E Alejandro ; Matsuura, Naomi ; Ronald, John A ; Shuhendler, Adam ; Weber, Wolfgang A ; Gilad, Assaf A ; Müller, Cristina ; Witney, Timothy H ; Chen, Xiaoyuan</creatorcontrib><description>Cancer has remained a formidable challenge in medicine and has claimed an enormous number of lives worldwide. Theranostics, combining diagnostic methods with personalized therapeutic approaches, shows huge potential to advance the battle against cancer. This review aims to provide an overview of theranostics in oncology: exploring its history, current advances, challenges, and prospects. We present the fundamental evolution of theranostics from radiotherapeutics, cellular therapeutics, and nanotherapeutics, showcasing critical milestones in the last decade. From the early concept of targeted drug delivery to the emergence of personalized medicine, theranostics has benefited from advances in imaging technologies, molecular biology, and nanomedicine. Furthermore, we emphasize pertinent illustrations showcasing that revolutionary strategies in cancer management enhance diagnostic accuracy and provide targeted therapies customized for individual patients, thereby facilitating the implementation of personalized medicine. Finally, we describe future perspectives on current challenges, emerging topics, and advances in the field.</description><identifier>ISSN: 1838-7640</identifier><identifier>EISSN: 1838-7640</identifier><identifier>DOI: 10.7150/thno.96675</identifier><identifier>PMID: 38646648</identifier><language>eng</language><publisher>Australia: Ivyspring International Publisher</publisher><subject>Review</subject><ispartof>Theranostics, 2024-01, Vol.14 (6), p.2464-2488</ispartof><rights>The author(s).</rights><rights>The author(s) 2024</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11024861/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11024861/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38646648$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Song, Yangmeihui</creatorcontrib><creatorcontrib>Zou, Jianhua</creatorcontrib><creatorcontrib>Castellanos, E Alejandro</creatorcontrib><creatorcontrib>Matsuura, Naomi</creatorcontrib><creatorcontrib>Ronald, John A</creatorcontrib><creatorcontrib>Shuhendler, Adam</creatorcontrib><creatorcontrib>Weber, Wolfgang A</creatorcontrib><creatorcontrib>Gilad, Assaf A</creatorcontrib><creatorcontrib>Müller, Cristina</creatorcontrib><creatorcontrib>Witney, Timothy H</creatorcontrib><creatorcontrib>Chen, Xiaoyuan</creatorcontrib><title>Theranostics - a sure cure for cancer after 100 years?</title><title>Theranostics</title><addtitle>Theranostics</addtitle><description>Cancer has remained a formidable challenge in medicine and has claimed an enormous number of lives worldwide. Theranostics, combining diagnostic methods with personalized therapeutic approaches, shows huge potential to advance the battle against cancer. This review aims to provide an overview of theranostics in oncology: exploring its history, current advances, challenges, and prospects. We present the fundamental evolution of theranostics from radiotherapeutics, cellular therapeutics, and nanotherapeutics, showcasing critical milestones in the last decade. From the early concept of targeted drug delivery to the emergence of personalized medicine, theranostics has benefited from advances in imaging technologies, molecular biology, and nanomedicine. Furthermore, we emphasize pertinent illustrations showcasing that revolutionary strategies in cancer management enhance diagnostic accuracy and provide targeted therapies customized for individual patients, thereby facilitating the implementation of personalized medicine. Finally, we describe future perspectives on current challenges, emerging topics, and advances in the field.</description><subject>Review</subject><issn>1838-7640</issn><issn>1838-7640</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNpVkE1Lw0AQhhdRbKm9-AMkRxFSd7ufORUpfkHBSz0vk83ERtJs3U2F_nsTW0udw8zAvLzv8BByzehEM0nv21XjJ5lSWp6RITPcpFoJen6yD8g4xk_alaDTjGWXZMCNEkoJMyRqucIAjY9t5WKSJpDEbcDE9a30IXHQOAwJlG3XGaXJDiHE2RW5KKGOOD7MEXl_elzOX9LF2_Pr_GGROs5NmxYcWAagIC_K0jAOOheUMskdSMimugA0ijpZcJQF1YLnQirkRqARCpzhIzLb-262-RoLh00boLabUK0h7KyHyv6_NNXKfvhvyxidCqNY53B7cAj-a4uxtesqOqxraNBvo-VUcK2NzPqwu73UBR9jwPKYw6jtYdsetv2F3YlvTj87Sv_Q8h9ts3nY</recordid><startdate>20240101</startdate><enddate>20240101</enddate><creator>Song, Yangmeihui</creator><creator>Zou, Jianhua</creator><creator>Castellanos, E Alejandro</creator><creator>Matsuura, Naomi</creator><creator>Ronald, John A</creator><creator>Shuhendler, Adam</creator><creator>Weber, Wolfgang A</creator><creator>Gilad, Assaf A</creator><creator>Müller, Cristina</creator><creator>Witney, Timothy H</creator><creator>Chen, Xiaoyuan</creator><general>Ivyspring International Publisher</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20240101</creationdate><title>Theranostics - a sure cure for cancer after 100 years?</title><author>Song, Yangmeihui ; Zou, Jianhua ; Castellanos, E Alejandro ; Matsuura, Naomi ; Ronald, John A ; Shuhendler, Adam ; Weber, Wolfgang A ; Gilad, Assaf A ; Müller, Cristina ; Witney, Timothy H ; Chen, Xiaoyuan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c338t-d3a19aa6abdff813a7b400153ca5a927dae860c5d3e5d0743b456e384e846ac83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Review</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Song, Yangmeihui</creatorcontrib><creatorcontrib>Zou, Jianhua</creatorcontrib><creatorcontrib>Castellanos, E Alejandro</creatorcontrib><creatorcontrib>Matsuura, Naomi</creatorcontrib><creatorcontrib>Ronald, John A</creatorcontrib><creatorcontrib>Shuhendler, Adam</creatorcontrib><creatorcontrib>Weber, Wolfgang A</creatorcontrib><creatorcontrib>Gilad, Assaf A</creatorcontrib><creatorcontrib>Müller, Cristina</creatorcontrib><creatorcontrib>Witney, Timothy H</creatorcontrib><creatorcontrib>Chen, Xiaoyuan</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Theranostics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Song, Yangmeihui</au><au>Zou, Jianhua</au><au>Castellanos, E Alejandro</au><au>Matsuura, Naomi</au><au>Ronald, John A</au><au>Shuhendler, Adam</au><au>Weber, Wolfgang A</au><au>Gilad, Assaf A</au><au>Müller, Cristina</au><au>Witney, Timothy H</au><au>Chen, Xiaoyuan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Theranostics - a sure cure for cancer after 100 years?</atitle><jtitle>Theranostics</jtitle><addtitle>Theranostics</addtitle><date>2024-01-01</date><risdate>2024</risdate><volume>14</volume><issue>6</issue><spage>2464</spage><epage>2488</epage><pages>2464-2488</pages><issn>1838-7640</issn><eissn>1838-7640</eissn><abstract>Cancer has remained a formidable challenge in medicine and has claimed an enormous number of lives worldwide. Theranostics, combining diagnostic methods with personalized therapeutic approaches, shows huge potential to advance the battle against cancer. This review aims to provide an overview of theranostics in oncology: exploring its history, current advances, challenges, and prospects. We present the fundamental evolution of theranostics from radiotherapeutics, cellular therapeutics, and nanotherapeutics, showcasing critical milestones in the last decade. From the early concept of targeted drug delivery to the emergence of personalized medicine, theranostics has benefited from advances in imaging technologies, molecular biology, and nanomedicine. Furthermore, we emphasize pertinent illustrations showcasing that revolutionary strategies in cancer management enhance diagnostic accuracy and provide targeted therapies customized for individual patients, thereby facilitating the implementation of personalized medicine. Finally, we describe future perspectives on current challenges, emerging topics, and advances in the field.</abstract><cop>Australia</cop><pub>Ivyspring International Publisher</pub><pmid>38646648</pmid><doi>10.7150/thno.96675</doi><tpages>25</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1838-7640 |
ispartof | Theranostics, 2024-01, Vol.14 (6), p.2464-2488 |
issn | 1838-7640 1838-7640 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11024861 |
source | PubMed Central Open Access; EZB-FREE-00999 freely available EZB journals; PubMed Central |
subjects | Review |
title | Theranostics - a sure cure for cancer after 100 years? |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T13%3A06%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Theranostics%20-%20a%20sure%20cure%20for%20cancer%20after%20100%20years?&rft.jtitle=Theranostics&rft.au=Song,%20Yangmeihui&rft.date=2024-01-01&rft.volume=14&rft.issue=6&rft.spage=2464&rft.epage=2488&rft.pages=2464-2488&rft.issn=1838-7640&rft.eissn=1838-7640&rft_id=info:doi/10.7150/thno.96675&rft_dat=%3Cproquest_pubme%3E3043778598%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3043778598&rft_id=info:pmid/38646648&rfr_iscdi=true |